Bacterial nasopharyngeal carriage following infant immunization with pneumococcal conjugate vaccines according to a 2+1 schedule in children in South Africa: an exploratory analysis of two clinical trials

References

• Simell B, Auranen K, Kayhty H, et al. The fundamental link between pneumococcal carriage and disease. Expert Rev Vaccines. 2012;11(7):841–1190.
   PubMed Web of Science ®Google Scholar
• Principi N, Esposito S. Serological criteria and carriage measurement for evaluation of new pneumococcal vaccines. Hum Vaccin Immunother. 2015;11(6):1494–1500.
   PubMed Web of Science ®Google Scholar
• Weinberger DM, Bruden DT, Grant LR, et al. Using pneumococcal carriage data to monitor postvaccination changes in invasive disease. Am J Epidemiol. 2013;178(9):1488–1495.
   PubMed Web of Science ®Google Scholar
• Flasche S, Givon-Lavi N, Dagan R. Using pneumococcal carriage data to monitor postvaccination changes in the incidence of pneumococcal otitis media. Am J Epidemiol. 2016;184(9):652–659.
   PubMed Web of Science ®Google Scholar
• Devine VT, Cleary DW, Jefferies JM, et al. The rise and fall of pneumococcal serotypes carried in the PCV era. Vaccine. 2017;35(9):1293–1298.
   PubMed Web of Science ®Google Scholar
• Nzenze SA, Madhi SA, Shiri T, et al. Imputing the direct and indirect effectiveness of childhood pneumococcal conjugate vaccine against invasive pneumococcal disease by surveying temporal changes in nasopharyngeal pneumococcal colonization. Am J Epidemiol. 2017;186(4):435–444.
   PubMed Web of Science ®Google Scholar
• Satzke C, Turner P, Virolainen-Julkunen A, et al. Standard method for detecting upper respiratory carriage of Streptococcus pneumoniae: updated recommendations from the World Health Organization Pneumococcal Carriage Working Group. Vaccine. 32(1): 165–179. 2013.
   PubMed Web of Science ®Google Scholar
• Dagan R, Givon-Lavi N, Porat N, et al. The effect of an alternative reduced-dose infant schedule and a second year catch-up schedule with 7-valent pneumococcal conjugate vaccine on pneumococcal carriage: a randomized controlled trial. Vaccine. 2012;30(34):5132–5140.
   PubMed Web of Science ®Google Scholar
• Fleming-Dutra KE, Conklin L, Loo JD, et al. Systematic review of the effect of pneumococcal conjugate vaccine dosing schedules on vaccine-type nasopharyngeal carriage. Pediatr Infect Dis J. 2014;33(Suppl 2):S152–160.
   PubMed Web of Science ®Google Scholar
• Spijkerman J, van Gils EJ, Veenhoven RH, et al. Carriage of Streptococcus pneumoniae 3 years after start of vaccination program, the Netherlands. Emerg Infect Dis. 2011;17(4):584–591.
   PubMed Web of Science ®Google Scholar
• Prymula R, Hanovcova I, Splino M, et al. Impact of the 10-valent pneumococcal non-typeable Haemophilus influenzae Protein D conjugate vaccine (PHiD-CV) on bacterial nasopharyngeal carriage. Vaccine. 2011;29(10):1959–1967.
   PubMed Web of Science ®Google Scholar
• van den Bergh MR, Spijkerman J, Swinnen KM, et al. Effects of the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D-conjugate vaccine on nasopharyngeal bacterial colonization in young children: a randomized controlled trial. Clin Infect Dis. 2013;56(3):e30–e39.
   PubMed Web of Science ®Google Scholar
• Hammitt LL, Ojal J, Bashraheil M, et al. Immunogenicity, impact on carriage and reactogenicity of 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine in Kenyan children aged 1-4 years: a randomized controlled trial. PLoS One. 2014;9(1):e85459.
   PubMed Web of Science ®Google Scholar
• Vesikari T, Forsten A, Seppa I, et al. Effectiveness of the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D-conjugated vaccine (PHiD-CV) against carriage and acute otitis media-a double-blind randomized clinical trial in Finland. J Pediatric Infect Dis Soc. 2016;5(3):237–248.
   PubMed Web of Science ®Google Scholar
• Sáez-Llorens X, Rowley S, Wong D, et al. Efficacy of 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine against acute otitis media and nasopharyngeal carriage in Panamanian children – A randomized controlled trial. Hum Vaccin Immunother. 2017;13(6):1213–1228.
   PubMed Web of Science ®Google Scholar
• Brandileone MC, Zanella RC, Almeida SC, et al. Effect of 10-valent pneumococcal conjugate vaccine on nasopharyngeal carriage of Streptococcus pneumoniae and Haemophilus influenzae among children in Sao Paulo, Brazil. Vaccine. 2016;34(46):5604–5611.
   PubMed Web of Science ®Google Scholar
• Odutola A, Ota MOC, Antonio M, et al. Efficacy of a novel, protein-based pneumococcal vaccine against nasopharyngeal carriage of Streptococcus pneumoniae in infants: A phase 2, randomized, controlled, observer-blind study. Vaccine. 2017;35(19):2531–2542.
   PubMed Web of Science ®Google Scholar
• Andrade AL, Ternes YM, Vieira MA, et al. Direct effect of 10-valent conjugate pneumococcal vaccination on pneumococcal carriage in children Brazil. PLoS One. 2014;9(6):e98128.
   PubMed Web of Science ®Google Scholar
• Davis SM, Deloria-Knoll M, Kassa HT, et al. Impact of pneumococcal conjugate vaccines on nasopharyngeal carriage and invasive disease among unvaccinated people: review of evidence on indirect effects. Vaccine. 2013;32(1):133–145.
   PubMed Web of Science ®Google Scholar
• Spijkerman J, Prevaes SM, van Gils EJ, et al. Long-term effects of pneumococcal conjugate vaccine on nasopharyngeal carriage of S. pneumoniae, S. aureus, H. influenzae and M. catarrhalis. PLoS One. 2012;7(6):e39730.
   PubMed Web of Science ®Google Scholar
• Bosch A, van Houten MA, Bruin JP, et al. Nasopharyngeal carriage of Streptococcus pneumoniae and other bacteria in the 7th year after implementation of the pneumococcal conjugate vaccine in the Netherlands. Vaccine. 2016;34(4):531–539.
   PubMed Web of Science ®Google Scholar
• Dunne EM, Satzke C, Ratu FT, et al. Effect of ten-valent pneumococcal conjugate vaccine introduction on pneumococcal carriage in Fiji: results from four annual cross-sectional carriage surveys. Lancet Glob Health. 2018;6(12):e1375–e1385.
   PubMed Web of Science ®Google Scholar
• Quirk SJ, Haraldsson G, Erlendsdóttir H, et al. Effect of vaccination on pneumococci isolated from the nasopharynx of healthy children and the middle ear of children with otitis media in Iceland. J Clin Microbiol. 2018;56:12.
   Web of Science ®Google Scholar
• Vissers M, Wijmenga-Monsuur AJ, Knol MJ, et al. Increased carriage of non-vaccine serotypes with low invasive disease potential four years after switching to the 10-valent pneumococcal conjugate vaccine in The Netherlands. PLoS One. 2018;13(3):e0194823.
   PubMed Web of Science ®Google Scholar
• Navne JE, Koch A, Slotved HC, et al. Effect of the 13-valent pneumococcal conjugate vaccine on nasopharyngeal carriage by respiratory pathogens among Greenlandic children. Int J Circumpolar Health. 2017;76(1):1309504.
   PubMed Web of Science ®Google Scholar
• Reiss-Mandel A, Regev-Yochay G. Staphylococcus aureus and Streptococcus pneumoniae interaction and response to pneumococcal vaccination: myth or reality? Hum Vaccin Immunother. 2016;12(2):351–357.
   PubMed Web of Science ®Google Scholar
• Pneumococcal vaccines WHO position paper - 2012 - recommendations. Vaccine. 2012;30(32):4717–4718.
   PubMed Web of Science ®Google Scholar
• Expanded Programme on Immunisation in South Africa. Vaccinator’s manual. [ cited 2020 Mar 18]. Available from: https://www.health-e.org.za/wp-content/uploads/2014/03/Vaccinators_Manual_Final.pdf
   Google Scholar
• Madhi SA, Cohen C, von Gottberg A. Introduction of pneumococcal conjugate vaccine into the public immunization program in South Africa: translating research into policy. Vaccine. 2012;30(Suppl 3):C21–27.
   PubMed Web of Science ®Google Scholar
• Hamaluba M, Kandasamy R, Upreti SR, et al. Comparison of two-dose priming plus 9-month booster with a standard three-dose priming schedule for a ten-valent pneumococcal conjugate vaccine in Nepalese infants: a randomised, controlled, open-label, non-inferiority trial. Lancet Infect Dis. 2015;15(4):405–414.
   PubMed Web of Science ®Google Scholar
• Klugman KP, Madhi SA, Adegbola RA, et al. Timing of serotype 1 pneumococcal disease suggests the need for evaluation of a booster dose. Vaccine. 2011;29(18):3372–3373.
   PubMed Web of Science ®Google Scholar
• WHO. Summary of WHO position papers - recommended routine immunizations for children. [ cited 2020 Mar 18]. Available from: http://www.who.int/immunization/policy/Immunization_routine_table2.pdf
   Google Scholar
• Madhi SA, Nunes MC. The potential impact of pneumococcal conjugate vaccine in Africa: considerations and early lessons learned from the South African experience. Hum Vaccin Immunother. 2016;12(2):314–325.
   PubMed Web of Science ®Google Scholar
• WHO. Vaccine-preventable diseases: coverage time series for South Africa. [ cited 2020 Mar 18]. Available from: http://apps.who.int/immunization_monitoring/globalsummary/coverages?c=ZAF
   Google Scholar
• Nunes MC, Jones SA, Groome MJ, et al. Acquisition of Streptococcus pneumoniae in South African children vaccinated with 7-valent pneumococcal conjugate vaccine at 6, 14 and 40 weeks of age. Vaccine. 2015;33(5):628–634.
   PubMed Web of Science ®Google Scholar
• Madhi SA, Moreira M, Koen A, et al. Impact of HIV status and vaccination schedule on bacterial nasopharyngeal carriage following infant immunisation with the pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine in South Africa. Vaccine. 2020;38(10):2350–2360.
   PubMed Web of Science ®Google Scholar
• Jones SA, Groome M, Koen A, et al. Immunogenicity of seven-valent pneumococcal conjugate vaccine administered at 6, 14 and 40 weeks of age in South African infants. PLoS One. 2013;8(8):e72794.
   PubMed Web of Science ®Google Scholar
• Madhi SA, Koen A, Jose L, et al. Vaccination with 10-valent pneumococcal conjugate vaccine in infants according to HIV status. Medicine (Baltimore). 2017;96(2):e5881.
   PubMed Web of Science ®Google Scholar
• Madhi SA, Koen A, Jose L, et al. Immunization with 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) according to different schedules in infants in South Africa: a phase III trial. Expert Rev Vaccines. 2017;16(6):641–656.
   PubMed Web of Science ®Google Scholar
• Neufeld F. Über die Agglutination der Pneumokokken und über die Theorieen der Agglutination. Z Hyg Infektionskr. 1902;40:54–72.
   Google Scholar
• Hammitt LL, Akech DO, Morpeth SC, et al. Population effect of 10-valent pneumococcal conjugate vaccine on nasopharyngeal carriage of Streptococcus pneumoniae and non-typeable Haemophilus influenzae in Kilifi, Kenya: findings from cross-sectional carriage studies. Lancet Glob Health. 2014;2(7):e397–405.
   PubMed Web of Science ®Google Scholar
• Roca A, Hill PC, Townend J, et al. Effects of community-wide vaccination with PCV-7 on pneumococcal nasopharyngeal carriage in the Gambia: a cluster-randomized trial. PLoS Med. 2011;8(10):e1001107.
   PubMed Web of Science ®Google Scholar
• Usuf E, Bottomley C, Adegbola RA, et al. Pneumococcal carriage in sub-Saharan Africa–a systematic review. PLoS One. 2014;9(1):e85001.
   PubMed Web of Science ®Google Scholar
• Sime WT, Aseffa A, Woldeamanuel Y, et al. Serotype and molecular diversity of nasopharyngeal Streptococcus pneumoniae isolates from children before and after vaccination with the ten-valent pneumococcal conjugate vaccine (PCV10) in Ethiopia. BMC Infect Dis. 2019;19(1):409.
   PubMed Web of Science ®Google Scholar
• K L O, Dagan R. Nasopharyngeal carriage. Pneumococcal vaccines. Washington, DC: American Society for Microbiology press; 2008.
   Google Scholar
• Olwagen CP, Adrian PV, Nunes MC, et al. Use of multiplex quantitative PCR to evaluate the impact of pneumococcal conjugate vaccine on nasopharyngeal pneumococcal colonization in African children. mSphere. 2017;2:6.
   Web of Science ®Google Scholar
• Abdullahi O, Karani A, Tigoi CC, et al. Rates of acquisition and clearance of pneumococcal serotypes in the nasopharynges of children in Kilifi District, Kenya. J Infect Dis. 2012;206(7):1020–1029.
   PubMed Web of Science ®Google Scholar
• Adegbola RA, DeAntonio R, Hill PC, et al. Carriage of Streptococcus pneumoniae and other respiratory bacterial pathogens in low and lower-middle income countries: a systematic review and meta-analysis. PLoS One. 2014;9(8):e103293.
   PubMed Web of Science ®Google Scholar
• Shiri T, Nunes MC, Adrian PV, et al. Interrelationship of Streptococcus pneumoniae, Haemophilus influenzae and Staphylococcus aureus colonization within and between pneumococcal-vaccine naive mother-child dyads. BMC Infect Dis. 2013;13:483.
   PubMed Web of Science ®Google Scholar
• Bojang A, Jafali J, Egere UE, et al. Seasonality of pneumococcal nasopharyngeal carriage in rural gambia determined within the context of a cluster randomized pneumococcal vaccine trial. PLoS One. 2015;10(7):e0129649.
   PubMed Web of Science ®Google Scholar
• Boyles TH, Brink A, Calligaro GL, et al. South African guideline for the management of community-acquired pneumonia in adults. J Thorac Dis. 2017;9(6):1469–1502.
   PubMed Web of Science ®Google Scholar
• Heinsbroek E, Tafatatha T, Chisambo C, et al. Pneumococcal acquisition among infants exposed to HIV in rural Malawi: a longitudinal household study. Am J Epidemiol. 2016;183(1):70–78.
   PubMed Web of Science ®Google Scholar
• Dube FS, Ramjith J, Gardner-Lubbe S, et al. Longitudinal characterization of nasopharyngeal colonization with Streptococcus pneumoniae in a South African birth cohort post 13-valent pneumococcal conjugate vaccine implementation. Sci Rep. 2018;8(1):12497.
   PubMed Web of Science ®Google Scholar
• Salter SJ, Turner C, Watthanaworawit W, et al. A longitudinal study of the infant nasopharyngeal microbiota: the effects of age, illness and antibiotic use in a cohort of South East Asian children. PLoS Negl Trop Dis. 2017;11(10):e0005975.
   PubMed Web of Science ®Google Scholar
• Nzenze SA, Shiri T, Nunes MC, et al. Temporal changes in pneumococcal colonization in a rural African community with high HIV prevalence following routine infant pneumococcal immunization. Pediatr Infect Dis J. 2013;32(11):1270–1278.
   PubMed Web of Science ®Google Scholar
• Nzenze SA, Shiri T, Nunes MC, et al. Temporal association of infant immunisation with pneumococcal conjugate vaccine on the ecology of Streptococcus pneumoniae, Haemophilus influenzae and Staphylococcus aureus nasopharyngeal colonisation in a rural South African community. Vaccine. 2014;32(42):5520–5530.
   PubMed Web of Science ®Google Scholar